Cytori Therapeutics Inc Series S Warrant
CYTXZ
CYTXZ was delisted on the 23rd of July, 2019.
7 hedge funds and large institutions have $273K invested in Cytori Therapeutics Inc Series S Warrant in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
13% less capital invested
Capital invested by funds: $314K → $273K (-$41K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$555 |
Top Sellers
CYTXZ Hedge Fund Activity: Q1 2019 in Review
7 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Series S Warrant (CYTXZ) for Q1 2019, worth a combined $273K — down 13% from $314K a quarter earlier.
Fund positioning in CYTXZ was balanced in Q1 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $555.
- 7 institutional investors held Cytori Therapeutics Inc Series S Warrant (CYTXZ) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $273K of Cytori Therapeutics Inc Series S Warrant stock for Q1 2019, down 13% quarter-over-quarter.
- 0 funds opened new Cytori Therapeutics Inc Series S Warrant positions in Q1 2019 and 0 closed out.
- The largest Cytori Therapeutics Inc Series S Warrant buyer in Q1 2019 was Susquehanna International Group, an estimated $555 added.
Based on aggregated 13F filings for Q1 2019.